Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158235 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yung-Lung Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung…. Hauptthemen laut MEDLINE: Apoptosis, Benzhydryl Compounds, Glucosides, Glucose. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Chang Gung Memorial Hospital, Kaohsiung Chang Gung Memorial Hospital, Taiwan.
Abstract (Originalsprache)
A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.
- Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
- School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung 804, Taiwan.
- Emergency Department, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.
ORCID-Profile: Yung-Lung Chen, Wen-Chin Lee, Pei-Ting Lin
Förderung
- Kaohsiung Chang Gung Memorial Hospital
- Kaohsiung Chang Gung Memorial Hospital, Taiwan
Zitieren
APA
Chen, Y. L., Wang, H. T., Lee, W. C., Lin, P. T., Liu, W. H., & Hsueh, S. K. (2024). Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158235
Vancouver
Chen YL, Wang HT, Lee WC, Lin PT, Liu WH, Hsueh SK. Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158235
BibTeX
@article{Chen2024,
author = {Chen, Yung-Lung and Wang, Hui-Ting and Lee, Wen-Chin and Lin, Pei-Ting and Liu, Wen-Hao and Hsueh, Shu-Kai},
title = {Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158235}
}
EUVIMED